Dernières nouvelles pour Astellas Pharma (OTC:ALPMF) Stock

Astellas Pharma Inc is a specialty global pharmaceutical company. The company focuses on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. The company operates its business in approximately 70 countries around the world. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.

ASTELLAS PHARMA INC by Astellas Pharma, Inc.

Comments

Astellas Pharma

Actualités

Dernières nouvelles pour Astellas Pharma (OTC:ALPMF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL